View ValuationAdvanced Nano Products 향후 성장Future 기준 점검 5/6Advanced Nano Products (는) 각각 연간 97.9% 및 34.1% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 66.6% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 11.2% 로 예상됩니다.핵심 정보97.9%이익 성장률66.56%EPS 성장률Chemicals 이익 성장63.8%매출 성장률34.1%향후 자기자본이익률11.23%애널리스트 커버리지Low마지막 업데이트12 May 2026최근 향후 성장 업데이트Price Target Changed • May 14Price target increased by 13% to ₩97,500Up from ₩86,500, the current price target is an average from 2 analysts. New target price is 29% above last closing price of ₩75,800. Stock is up 41% over the past year. The company is forecast to post earnings per share of ₩711 for next year compared to ₩136 last year.Major Estimate Revision • Apr 11Consensus EPS estimates fall by 34%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from ₩159.0m to ₩148.6m. EPS estimate also fell from ₩1,037 per share to ₩681 per share. Net income forecast to grow 512% next year vs 62% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩82,667 to ₩79,333. Share price rose 9.6% to ₩68,800 over the past week.Price Target Changed • May 13Price target decreased by 36% to ₩95,000Down from ₩148,750, the current price target is an average from 4 analysts. New target price is 78% above last closing price of ₩53,400. Stock is down 52% over the past year. The company is forecast to post earnings per share of ₩492 next year compared to a net loss per share of ₩155 last year.Price Target Changed • Jun 11Price target decreased by 8.9% to ₩183,333Down from ₩201,333, the current price target is an average from 3 analysts. New target price is 52% above last closing price of ₩120,300. Stock is down 19% over the past year. The company is forecast to post earnings per share of ₩1,481 for next year compared to ₩1,489 last year.Price Target Changed • Apr 27Price target increased to ₩110,000Up from ₩90,000, the current price target is provided by 1 analyst. New target price is 60% above last closing price of ₩68,800. Stock is up 112% over the past year. The company posted earnings per share of ₩703 last year.모든 업데이트 보기Recent updatesPrice Target Changed • May 14Price target increased by 13% to ₩97,500Up from ₩86,500, the current price target is an average from 2 analysts. New target price is 29% above last closing price of ₩75,800. Stock is up 41% over the past year. The company is forecast to post earnings per share of ₩711 for next year compared to ₩136 last year.New Risk • Apr 24New major risk - Revenue and earnings growthEarnings have declined by 18% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (13% average weekly change).Major Estimate Revision • Apr 11Consensus EPS estimates fall by 34%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from ₩159.0m to ₩148.6m. EPS estimate also fell from ₩1,037 per share to ₩681 per share. Net income forecast to grow 512% next year vs 62% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩82,667 to ₩79,333. Share price rose 9.6% to ₩68,800 over the past week.Reported Earnings • Mar 20Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: ₩136 (up from ₩155 loss in FY 2024). Revenue: ₩111.7b (up 27% from FY 2024). Net income: ₩1.63b (up ₩3.49b from FY 2024). Profit margin: 1.5% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 78%. Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance.Buy Or Sell Opportunity • Feb 20Now 20% undervaluedOver the last 90 days, the stock has risen 31% to ₩71,200. The fair value is estimated to be ₩89,363, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Meanwhile, the company became loss making.New Risk • Feb 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.분석 기사 • Feb 06Revenues Tell The Story For Advanced Nano Products Co., Ltd. (KOSDAQ:121600) As Its Stock Soars 32%Advanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shares have had a really impressive month, gaining 32% after a shaky...Buy Or Sell Opportunity • Jan 30Now 22% undervaluedOver the last 90 days, the stock has risen 4.9% to ₩69,100. The fair value is estimated to be ₩88,516, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Meanwhile, the company became loss making.분석 기사 • Jan 22The Returns On Capital At Advanced Nano Products (KOSDAQ:121600) Don't Inspire ConfidenceTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Upcoming Dividend • Dec 22Upcoming dividend of ₩250 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 13 April 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%).New Risk • Dec 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.분석 기사 • Dec 01These 4 Measures Indicate That Advanced Nano Products (KOSDAQ:121600) Is Using Debt ExtensivelyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Declared Dividend • Nov 08Dividend of ₩250 announcedDividend of ₩250 is the same as last year. Ex-date: 29th December 2025 Payment date: 13th April 2026 Dividend yield will be 0.4%, which is lower than the industry average of 1.7%.분석 기사 • Nov 07After Leaping 33% Advanced Nano Products Co., Ltd. (KOSDAQ:121600) Shares Are Not Flying Under The RadarAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shares have had a really impressive month, gaining 33% after a shaky...공시 • Nov 07Advanced Nano Products Co., Ltd. announces Annual dividend, payable on April 13, 2026Advanced Nano Products Co., Ltd. announced Annual dividend of KRW 250.0000 per share payable on April 13, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.분석 기사 • Sep 16Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) Earnings Haven't Escaped The Attention Of InvestorsAdvanced Nano Products Co., Ltd.'s ( KOSDAQ:121600 ) price-to-sales (or "P/S") ratio of 6.1x may look like a poor...분석 기사 • Aug 11These 4 Measures Indicate That Advanced Nano Products (KOSDAQ:121600) Is Using Debt ExtensivelyKOSDAQ:A121600 1 Year Share Price vs Fair Value Explore Advanced Nano Products's Fair Values from the Community and...Price Target Changed • May 13Price target decreased by 36% to ₩95,000Down from ₩148,750, the current price target is an average from 4 analysts. New target price is 78% above last closing price of ₩53,400. Stock is down 52% over the past year. The company is forecast to post earnings per share of ₩492 next year compared to a net loss per share of ₩155 last year.Buy Or Sell Opportunity • Apr 30Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 19% to ₩53,900. The fair value is estimated to be ₩67,935, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company became loss making.New Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.분석 기사 • Apr 02Why We're Not Concerned Yet About Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) 25% Share Price PlungeAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders won't be pleased to see that the share price has had a...Buy Or Sell Opportunity • Apr 02Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.8% to ₩53,000. The fair value is estimated to be ₩66,936, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company became loss making.Reported Earnings • Mar 26Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: ₩155 loss per share (down from ₩1,489 profit in FY 2023). Revenue: ₩87.8b (up 5.5% from FY 2023). Net loss: ₩1.85b (down 111% from profit in FY 2023). Revenue missed analyst estimates by 12%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 46% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.공시 • Mar 05Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 31, 2025Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 31, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 243-2, techno jungang-ro, yuseong-gu, daejeon South KoreaBuy Or Sell Opportunity • Dec 30Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 38% to ₩58,200. The fair value is estimated to be ₩73,353, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 143% in 2 years. Earnings are forecast to grow by 625% in the next 2 years.Upcoming Dividend • Dec 20Upcoming dividend of ₩250 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 14 April 2025. Payout ratio is a comfortable 39% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%).분석 기사 • Nov 15Advanced Nano Products Co., Ltd. (KOSDAQ:121600) Shares Slammed 28% But Getting In Cheap Might Be Difficult RegardlessAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders that were waiting for something to happen have been...Valuation Update With 7 Day Price Move • Nov 11Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩75,900, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total returns to shareholders of 22% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩73,855 per share.Buy Or Sell Opportunity • Nov 05Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 7.1% to ₩90,000. The fair value is estimated to be ₩74,944, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has grown by 18%. Revenue is forecast to grow by 182% in 2 years. Earnings are forecast to grow by 228% in the next 2 years.분석 기사 • Oct 20Calculating The Intrinsic Value Of Advanced Nano Products Co., Ltd. (KOSDAQ:121600)Key Insights Advanced Nano Products' estimated fair value is ₩74,447 based on 2 Stage Free Cash Flow to Equity Current...분석 기사 • Sep 26Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) Popularity With Investors Is ClearWhen you see that almost half of the companies in the Chemicals industry in Korea have price-to-sales ratios (or "P/S...분석 기사 • Sep 02Advanced Nano Products (KOSDAQ:121600) Will Want To Turn Around Its Return TrendsTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₩74,900, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 100% over the past three years.Price Target Changed • Jun 11Price target decreased by 8.9% to ₩183,333Down from ₩201,333, the current price target is an average from 3 analysts. New target price is 52% above last closing price of ₩120,300. Stock is down 19% over the past year. The company is forecast to post earnings per share of ₩1,481 for next year compared to ₩1,489 last year.New Risk • May 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 15% Last year net profit margin: 25% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (53% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (15% net profit margin). Shareholders have been diluted in the past year (13% increase in shares outstanding).분석 기사 • Mar 23Advanced Nano Products' (KOSDAQ:121600) Problems Go Beyond Poor ProfitAfter announcing weak earnings, Advanced Nano Products Co., Ltd.'s ( KOSDAQ:121600 ) stock was strong. Despite the...분석 기사 • Mar 21Revenues Tell The Story For Advanced Nano Products Co., Ltd. (KOSDAQ:121600) As Its Stock Soars 33%Advanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders would be excited to see that the share price has had a...Reported Earnings • Mar 20Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2023 results: EPS: ₩1,489 (down from ₩1,811 in FY 2022). Revenue: ₩83.2b (up 4.1% from FY 2022). Net income: ₩16.8b (down 13% from FY 2022). Profit margin: 20% (down from 24% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) exceeded analyst estimates by 1.4%. Revenue is forecast to grow 63% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has increased by 71% per year, which means it is tracking significantly ahead of earnings growth.분석 기사 • Mar 15Some Investors May Be Worried About Advanced Nano Products' (KOSDAQ:121600) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...New Risk • Feb 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Profit margins are more than 30% lower than last year (15% net profit margin). Shareholders have been diluted in the past year (12% increase in shares outstanding).Upcoming Dividend • Dec 20Upcoming dividend of ₩250 per share at 0.2% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 15 April 2024. Payout ratio is a comfortable 23% but the company is not cash flow positive. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%).Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩377 (vs ₩952 in 3Q 2022)Third quarter 2023 results: EPS: ₩377 (down from ₩952 in 3Q 2022). Revenue: ₩20.5b (down 4.8% from 3Q 2022). Net income: ₩4.40b (down 56% from 3Q 2022). Profit margin: 21% (down from 47% in 3Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 66% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 58% per year whereas the company’s share price has increased by 54% per year.New Risk • Sep 10New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (21% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Shareholders have been diluted in the past year (11% increase in shares outstanding).New Risk • Jun 21New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 7.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (22% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (9.4% average weekly change). Shareholders have been diluted in the past year (7.3% increase in shares outstanding).Reported Earnings • Mar 23Full year 2022 earnings released: EPS: ₩1,811 (vs ₩703 in FY 2021)Full year 2022 results: EPS: ₩1,811 (up from ₩703 in FY 2021). Revenue: ₩79.9b (up 31% from FY 2021). Net income: ₩19.2b (up 158% from FY 2021). Profit margin: 24% (up from 12% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 52% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has increased by 145% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩109,200, the stock trades at a trailing P/E ratio of 53x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 486% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩146,761 per share.Upcoming Dividend • Dec 21Upcoming dividend of ₩120 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is a comfortable 5.8% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Sep 19Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩81,500, the stock trades at a trailing P/E ratio of 60x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 436% over the past three years.Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩96,900, the stock trades at a trailing P/E ratio of 71.4x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 489% over the past three years.Valuation Update With 7 Day Price Move • Jul 01Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩67,400, the stock trades at a trailing P/E ratio of 78.5x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 265% over the past three years.Reported Earnings • May 18First quarter 2022 earnings released: EPS: ₩371 (vs ₩216 in 1Q 2021)First quarter 2022 results: EPS: ₩371 (up from ₩216 in 1Q 2021). Revenue: ₩18.8b (up 29% from 1Q 2021). Net income: ₩3.93b (up 73% from 1Q 2021). Profit margin: 21% (up from 16% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 64%, compared to a 23% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 64% per year, which means it is tracking significantly ahead of earnings growth.Price Target Changed • Apr 27Price target increased to ₩110,000Up from ₩90,000, the current price target is provided by 1 analyst. New target price is 60% above last closing price of ₩68,800. Stock is up 112% over the past year. The company posted earnings per share of ₩703 last year.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₩51,300, the stock trades at a trailing P/E ratio of 79.4x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 203% over the past three years.Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 18 April 2022. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.4%).공시 • May 25Advanced Nano Products Co., Ltd. announced that it expects to receive KRW 2.00006714 billion in funding from KDB Capital Corporation, Investment ArmAdvanced Nano Products Co., Ltd. (KOSDAQ:A121600) announced that it will issue 68,620 redeemable preferred stock of face value of KRW 500 per share at issue price of KRW 29,147 per share for gross proceeds of KRW 2,000,067,140 on May 24, 2021. The transaction will include participation from KDB Capital Corporation, Investment Arm. The transaction is through third party allotment method. The preferred shares will be redeemable at KRW 29,147 per share beginning from December 1, 2024 to December 31, 2024. The transaction is expected to close on June 25, 2021. The eligibility data for dividend payout on new shares is January 1, 2021. The transaction has been approved by the board of directors of the company. The preferred shares are subject to a lock up period of one year.분석 기사 • Apr 07Is Advanced Nano Products (KOSDAQ:121600) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...분석 기사 • Mar 16Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?Advanced Nano Products (KOSDAQ:121600) has had a great run on the share market with its stock up by a significant 20...분석 기사 • Feb 23Investors In Advanced Nano Products Co., Ltd. (KOSDAQ:121600) Should Consider This, FirstDividend paying stocks like Advanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) tend to be popular with investors, and...Is New 90 Day High Low • Feb 23New 90-day low: ₩31,250The company is down 4.0% from its price of ₩32,650 on 25 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period.공시 • Feb 20Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 29, 2021Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 29, 2021, at 10:00 Korea Standard Time.분석 기사 • Feb 02If You Had Bought Advanced Nano Products (KOSDAQ:121600) Shares A Year Ago You'd Have Earned 90% ReturnsAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders have seen the share price descend 12% over the month...분석 기사 • Jan 12Is Advanced Nano Products (KOSDAQ:121600) Likely To Turn Things Around?There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...Is New 90 Day High Low • Jan 11New 90-day high: ₩40,000The company is up 24% from its price of ₩32,350 on 13 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 32% over the same period.분석 기사 • Dec 22Advanced Nano Products (KOSDAQ:121600) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Upcoming Dividend • Dec 22Upcoming Dividend of ₩120 Per ShareWill be paid on the 17th of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.3% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (0.9%).Is New 90 Day High Low • Dec 21New 90-day high: ₩39,500The company is up 7.0% from its price of ₩36,800 on 22 September 2020. The South Korean market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.Is New 90 Day High Low • Oct 26New 90-day low: ₩27,500The company is down 2.0% from its price of ₩28,200 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.이익 및 매출 성장 예측KOSDAQ:A121600 - 애널리스트 향후 추정치 및 과거 재무 데이터 (KRW Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/2028313,252117,600N/A30,000212/31/2027218,21617,200N/A-1,000212/31/2026147,7059,100N/A34,000212/31/2025111,7451,6354,65016,754N/A9/30/2025105,597-5,264-5,5487,165N/A6/30/202595,963-6,391-7,89510,872N/A3/31/202587,745-2,240-7,41326,125N/A12/31/202487,767-1,853-26,28524,522N/A9/30/202486,6357,604-49,41615,006N/A6/30/202485,52611,515-55,90514,089N/A3/31/202487,87013,440-48,2649,608N/A12/31/202383,17016,774-30,2519,307N/A9/30/202380,37111,666-8,38320,977N/A6/30/202381,41117,352-54519,609N/A3/31/202378,74819,73142516,021N/A12/31/202279,91219,1742,49419,419N/A9/30/202276,70321,7065,78517,870N/A6/30/202271,44814,3582,79710,650N/A3/31/202265,2569,0787,76914,991N/A12/31/202161,0697,4306,26410,601N/A9/30/202159,9736,8263,8278,662N/A6/30/202155,6024,0311,8359,692N/A3/31/202152,1903,428-5,2393,634N/A12/31/202048,5241,650-4,8998,742N/A9/30/202045,8362,122-2,8549,844N/A6/30/202045,0614,0224,41913,741N/A3/31/202046,7434,4187,82015,855N/A12/31/201948,8935,8019,22311,904N/A9/30/201951,8366,190N/A9,256N/A6/30/201955,2506,774N/A6,847N/A3/31/201953,7227,781N/A5,254N/A12/31/201852,2507,672N/A3,947N/A9/30/201851,9077,749N/A7,030N/A6/30/201850,1738,248N/A6,905N/A3/31/201848,2098,116N/A5,062N/A12/31/201745,5696,828N/A9,556N/A9/30/201744,6418,239N/A6,484N/A6/30/201740,6395,539N/A3,943N/A3/31/201740,6375,208N/A6,453N/A12/31/201641,1125,940N/A6,589N/A9/30/201638,4093,692N/A13,662N/A6/30/201644,0117,542N/A16,530N/A3/31/201643,0687,539N/A14,395N/A12/31/201543,1407,656N/A11,682N/A9/30/201541,1108,915N/A5,246N/A6/30/201532,4735,033N/A1,706N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: A121600 의 연간 예상 수익 증가율(97.9%)이 saving rate(3.1%)보다 높습니다.수익 vs 시장: A121600 의 연간 수익(97.9%)이 KR 시장(29.3%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: A121600 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: A121600 의 수익(연간 34.1%)이 KR 시장(연간 16.5%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: A121600 의 수익(연간 34.1%)은 연간 20%보다 빠르게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: A121600의 자본 수익률은 3년 후 11.2%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/26 23:29종가2026/05/26 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Advanced Nano Products Co., Ltd.는 7명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Choi Soon-HoEugene Investment & Securities Co Ltd.Yushin ParkHSBCWon Suk ChungiM Securities4명의 분석가 더 보기
Price Target Changed • May 14Price target increased by 13% to ₩97,500Up from ₩86,500, the current price target is an average from 2 analysts. New target price is 29% above last closing price of ₩75,800. Stock is up 41% over the past year. The company is forecast to post earnings per share of ₩711 for next year compared to ₩136 last year.
Major Estimate Revision • Apr 11Consensus EPS estimates fall by 34%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from ₩159.0m to ₩148.6m. EPS estimate also fell from ₩1,037 per share to ₩681 per share. Net income forecast to grow 512% next year vs 62% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩82,667 to ₩79,333. Share price rose 9.6% to ₩68,800 over the past week.
Price Target Changed • May 13Price target decreased by 36% to ₩95,000Down from ₩148,750, the current price target is an average from 4 analysts. New target price is 78% above last closing price of ₩53,400. Stock is down 52% over the past year. The company is forecast to post earnings per share of ₩492 next year compared to a net loss per share of ₩155 last year.
Price Target Changed • Jun 11Price target decreased by 8.9% to ₩183,333Down from ₩201,333, the current price target is an average from 3 analysts. New target price is 52% above last closing price of ₩120,300. Stock is down 19% over the past year. The company is forecast to post earnings per share of ₩1,481 for next year compared to ₩1,489 last year.
Price Target Changed • Apr 27Price target increased to ₩110,000Up from ₩90,000, the current price target is provided by 1 analyst. New target price is 60% above last closing price of ₩68,800. Stock is up 112% over the past year. The company posted earnings per share of ₩703 last year.
Price Target Changed • May 14Price target increased by 13% to ₩97,500Up from ₩86,500, the current price target is an average from 2 analysts. New target price is 29% above last closing price of ₩75,800. Stock is up 41% over the past year. The company is forecast to post earnings per share of ₩711 for next year compared to ₩136 last year.
New Risk • Apr 24New major risk - Revenue and earnings growthEarnings have declined by 18% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (13% average weekly change).
Major Estimate Revision • Apr 11Consensus EPS estimates fall by 34%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from ₩159.0m to ₩148.6m. EPS estimate also fell from ₩1,037 per share to ₩681 per share. Net income forecast to grow 512% next year vs 62% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩82,667 to ₩79,333. Share price rose 9.6% to ₩68,800 over the past week.
Reported Earnings • Mar 20Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: ₩136 (up from ₩155 loss in FY 2024). Revenue: ₩111.7b (up 27% from FY 2024). Net income: ₩1.63b (up ₩3.49b from FY 2024). Profit margin: 1.5% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 78%. Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance.
Buy Or Sell Opportunity • Feb 20Now 20% undervaluedOver the last 90 days, the stock has risen 31% to ₩71,200. The fair value is estimated to be ₩89,363, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Feb 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
분석 기사 • Feb 06Revenues Tell The Story For Advanced Nano Products Co., Ltd. (KOSDAQ:121600) As Its Stock Soars 32%Advanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shares have had a really impressive month, gaining 32% after a shaky...
Buy Or Sell Opportunity • Jan 30Now 22% undervaluedOver the last 90 days, the stock has risen 4.9% to ₩69,100. The fair value is estimated to be ₩88,516, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Meanwhile, the company became loss making.
분석 기사 • Jan 22The Returns On Capital At Advanced Nano Products (KOSDAQ:121600) Don't Inspire ConfidenceTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Upcoming Dividend • Dec 22Upcoming dividend of ₩250 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 13 April 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%).
New Risk • Dec 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
분석 기사 • Dec 01These 4 Measures Indicate That Advanced Nano Products (KOSDAQ:121600) Is Using Debt ExtensivelyWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Declared Dividend • Nov 08Dividend of ₩250 announcedDividend of ₩250 is the same as last year. Ex-date: 29th December 2025 Payment date: 13th April 2026 Dividend yield will be 0.4%, which is lower than the industry average of 1.7%.
분석 기사 • Nov 07After Leaping 33% Advanced Nano Products Co., Ltd. (KOSDAQ:121600) Shares Are Not Flying Under The RadarAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shares have had a really impressive month, gaining 33% after a shaky...
공시 • Nov 07Advanced Nano Products Co., Ltd. announces Annual dividend, payable on April 13, 2026Advanced Nano Products Co., Ltd. announced Annual dividend of KRW 250.0000 per share payable on April 13, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.
분석 기사 • Sep 16Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) Earnings Haven't Escaped The Attention Of InvestorsAdvanced Nano Products Co., Ltd.'s ( KOSDAQ:121600 ) price-to-sales (or "P/S") ratio of 6.1x may look like a poor...
분석 기사 • Aug 11These 4 Measures Indicate That Advanced Nano Products (KOSDAQ:121600) Is Using Debt ExtensivelyKOSDAQ:A121600 1 Year Share Price vs Fair Value Explore Advanced Nano Products's Fair Values from the Community and...
Price Target Changed • May 13Price target decreased by 36% to ₩95,000Down from ₩148,750, the current price target is an average from 4 analysts. New target price is 78% above last closing price of ₩53,400. Stock is down 52% over the past year. The company is forecast to post earnings per share of ₩492 next year compared to a net loss per share of ₩155 last year.
Buy Or Sell Opportunity • Apr 30Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 19% to ₩53,900. The fair value is estimated to be ₩67,935, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
분석 기사 • Apr 02Why We're Not Concerned Yet About Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) 25% Share Price PlungeAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders won't be pleased to see that the share price has had a...
Buy Or Sell Opportunity • Apr 02Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.8% to ₩53,000. The fair value is estimated to be ₩66,936, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company became loss making.
Reported Earnings • Mar 26Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: ₩155 loss per share (down from ₩1,489 profit in FY 2023). Revenue: ₩87.8b (up 5.5% from FY 2023). Net loss: ₩1.85b (down 111% from profit in FY 2023). Revenue missed analyst estimates by 12%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 46% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
공시 • Mar 05Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 31, 2025Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 31, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 243-2, techno jungang-ro, yuseong-gu, daejeon South Korea
Buy Or Sell Opportunity • Dec 30Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 38% to ₩58,200. The fair value is estimated to be ₩73,353, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 143% in 2 years. Earnings are forecast to grow by 625% in the next 2 years.
Upcoming Dividend • Dec 20Upcoming dividend of ₩250 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 14 April 2025. Payout ratio is a comfortable 39% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%).
분석 기사 • Nov 15Advanced Nano Products Co., Ltd. (KOSDAQ:121600) Shares Slammed 28% But Getting In Cheap Might Be Difficult RegardlessAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders that were waiting for something to happen have been...
Valuation Update With 7 Day Price Move • Nov 11Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩75,900, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total returns to shareholders of 22% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩73,855 per share.
Buy Or Sell Opportunity • Nov 05Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 7.1% to ₩90,000. The fair value is estimated to be ₩74,944, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has grown by 18%. Revenue is forecast to grow by 182% in 2 years. Earnings are forecast to grow by 228% in the next 2 years.
분석 기사 • Oct 20Calculating The Intrinsic Value Of Advanced Nano Products Co., Ltd. (KOSDAQ:121600)Key Insights Advanced Nano Products' estimated fair value is ₩74,447 based on 2 Stage Free Cash Flow to Equity Current...
분석 기사 • Sep 26Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) Popularity With Investors Is ClearWhen you see that almost half of the companies in the Chemicals industry in Korea have price-to-sales ratios (or "P/S...
분석 기사 • Sep 02Advanced Nano Products (KOSDAQ:121600) Will Want To Turn Around Its Return TrendsTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₩74,900, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 100% over the past three years.
Price Target Changed • Jun 11Price target decreased by 8.9% to ₩183,333Down from ₩201,333, the current price target is an average from 3 analysts. New target price is 52% above last closing price of ₩120,300. Stock is down 19% over the past year. The company is forecast to post earnings per share of ₩1,481 for next year compared to ₩1,489 last year.
New Risk • May 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 15% Last year net profit margin: 25% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (53% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (15% net profit margin). Shareholders have been diluted in the past year (13% increase in shares outstanding).
분석 기사 • Mar 23Advanced Nano Products' (KOSDAQ:121600) Problems Go Beyond Poor ProfitAfter announcing weak earnings, Advanced Nano Products Co., Ltd.'s ( KOSDAQ:121600 ) stock was strong. Despite the...
분석 기사 • Mar 21Revenues Tell The Story For Advanced Nano Products Co., Ltd. (KOSDAQ:121600) As Its Stock Soars 33%Advanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders would be excited to see that the share price has had a...
Reported Earnings • Mar 20Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2023 results: EPS: ₩1,489 (down from ₩1,811 in FY 2022). Revenue: ₩83.2b (up 4.1% from FY 2022). Net income: ₩16.8b (down 13% from FY 2022). Profit margin: 20% (down from 24% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) exceeded analyst estimates by 1.4%. Revenue is forecast to grow 63% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has increased by 71% per year, which means it is tracking significantly ahead of earnings growth.
분석 기사 • Mar 15Some Investors May Be Worried About Advanced Nano Products' (KOSDAQ:121600) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...
New Risk • Feb 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Profit margins are more than 30% lower than last year (15% net profit margin). Shareholders have been diluted in the past year (12% increase in shares outstanding).
Upcoming Dividend • Dec 20Upcoming dividend of ₩250 per share at 0.2% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 15 April 2024. Payout ratio is a comfortable 23% but the company is not cash flow positive. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%).
Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩377 (vs ₩952 in 3Q 2022)Third quarter 2023 results: EPS: ₩377 (down from ₩952 in 3Q 2022). Revenue: ₩20.5b (down 4.8% from 3Q 2022). Net income: ₩4.40b (down 56% from 3Q 2022). Profit margin: 21% (down from 47% in 3Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 66% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 58% per year whereas the company’s share price has increased by 54% per year.
New Risk • Sep 10New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (21% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Shareholders have been diluted in the past year (11% increase in shares outstanding).
New Risk • Jun 21New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 7.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (22% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (9.4% average weekly change). Shareholders have been diluted in the past year (7.3% increase in shares outstanding).
Reported Earnings • Mar 23Full year 2022 earnings released: EPS: ₩1,811 (vs ₩703 in FY 2021)Full year 2022 results: EPS: ₩1,811 (up from ₩703 in FY 2021). Revenue: ₩79.9b (up 31% from FY 2021). Net income: ₩19.2b (up 158% from FY 2021). Profit margin: 24% (up from 12% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 52% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has increased by 145% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩109,200, the stock trades at a trailing P/E ratio of 53x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 486% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩146,761 per share.
Upcoming Dividend • Dec 21Upcoming dividend of ₩120 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is a comfortable 5.8% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Sep 19Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩81,500, the stock trades at a trailing P/E ratio of 60x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 436% over the past three years.
Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩96,900, the stock trades at a trailing P/E ratio of 71.4x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 489% over the past three years.
Valuation Update With 7 Day Price Move • Jul 01Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩67,400, the stock trades at a trailing P/E ratio of 78.5x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 265% over the past three years.
Reported Earnings • May 18First quarter 2022 earnings released: EPS: ₩371 (vs ₩216 in 1Q 2021)First quarter 2022 results: EPS: ₩371 (up from ₩216 in 1Q 2021). Revenue: ₩18.8b (up 29% from 1Q 2021). Net income: ₩3.93b (up 73% from 1Q 2021). Profit margin: 21% (up from 16% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 64%, compared to a 23% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 64% per year, which means it is tracking significantly ahead of earnings growth.
Price Target Changed • Apr 27Price target increased to ₩110,000Up from ₩90,000, the current price target is provided by 1 analyst. New target price is 60% above last closing price of ₩68,800. Stock is up 112% over the past year. The company posted earnings per share of ₩703 last year.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₩51,300, the stock trades at a trailing P/E ratio of 79.4x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 203% over the past three years.
Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 18 April 2022. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.4%).
공시 • May 25Advanced Nano Products Co., Ltd. announced that it expects to receive KRW 2.00006714 billion in funding from KDB Capital Corporation, Investment ArmAdvanced Nano Products Co., Ltd. (KOSDAQ:A121600) announced that it will issue 68,620 redeemable preferred stock of face value of KRW 500 per share at issue price of KRW 29,147 per share for gross proceeds of KRW 2,000,067,140 on May 24, 2021. The transaction will include participation from KDB Capital Corporation, Investment Arm. The transaction is through third party allotment method. The preferred shares will be redeemable at KRW 29,147 per share beginning from December 1, 2024 to December 31, 2024. The transaction is expected to close on June 25, 2021. The eligibility data for dividend payout on new shares is January 1, 2021. The transaction has been approved by the board of directors of the company. The preferred shares are subject to a lock up period of one year.
분석 기사 • Apr 07Is Advanced Nano Products (KOSDAQ:121600) Using Too Much Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
분석 기사 • Mar 16Advanced Nano Products Co., Ltd.'s (KOSDAQ:121600) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?Advanced Nano Products (KOSDAQ:121600) has had a great run on the share market with its stock up by a significant 20...
분석 기사 • Feb 23Investors In Advanced Nano Products Co., Ltd. (KOSDAQ:121600) Should Consider This, FirstDividend paying stocks like Advanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) tend to be popular with investors, and...
Is New 90 Day High Low • Feb 23New 90-day low: ₩31,250The company is down 4.0% from its price of ₩32,650 on 25 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period.
공시 • Feb 20Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 29, 2021Advanced Nano Products Co., Ltd., Annual General Meeting, Mar 29, 2021, at 10:00 Korea Standard Time.
분석 기사 • Feb 02If You Had Bought Advanced Nano Products (KOSDAQ:121600) Shares A Year Ago You'd Have Earned 90% ReturnsAdvanced Nano Products Co., Ltd. ( KOSDAQ:121600 ) shareholders have seen the share price descend 12% over the month...
분석 기사 • Jan 12Is Advanced Nano Products (KOSDAQ:121600) Likely To Turn Things Around?There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Is New 90 Day High Low • Jan 11New 90-day high: ₩40,000The company is up 24% from its price of ₩32,350 on 13 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 32% over the same period.
분석 기사 • Dec 22Advanced Nano Products (KOSDAQ:121600) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Upcoming Dividend • Dec 22Upcoming Dividend of ₩120 Per ShareWill be paid on the 17th of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.3% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (0.9%).
Is New 90 Day High Low • Dec 21New 90-day high: ₩39,500The company is up 7.0% from its price of ₩36,800 on 22 September 2020. The South Korean market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.
Is New 90 Day High Low • Oct 26New 90-day low: ₩27,500The company is down 2.0% from its price of ₩28,200 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.